 |
|
|
| |
Injection-Site Reactions More Common and Bothersome With Single Doses of Lenacapavir vs Cabotegravir
|
| |
| |
CROI 2026 Feb 22-25 Denver
Dainielle Fox,1 Justine Boles,2 Emilie Elliot,3 Apinya Vutikullird,4 Amber Mottola,4 Kim Fletcher,5 Kehui Wang,6 Suryakant Somvanshi,7 Richard Grove,5 Katherine L. Nelson,1 Laure Dupont-Benjamin,8 Piotr Budnik,2 Jean van Wyk,2 Harmony P. Garges,6 Kimberley Brown1
1ViiV Healthcare, Durham, NC, USA; 2ViiV Healthcare, London, UK; 3ViiV Healthcare, Madrid, Spain; 4Ark Clinical Research, Long Beach, CA, USA; 5GSK, London, UK; 6GSK, Durham, NC, USA; 7GSK, GCC, Bengaluru, India; 8ViiV Healthcare, Rueil-Malmaison, France
|
| |
|
|
|
|
|
